Spotlight on Gene Therapy: finding a Cure

Dr Mueller will be speaking at the CRISPR & Precision Genome Editing 2017 in Boston, on February 21st-22nd.

He will give a talk and present unpublished data on "Survival Advantage of Genome-Corrected Hepatocytes for Treatment of Alpha-1 Antitrypsin Deficiency".
He will also lead workshop B on "Taking CRISPR/Cas9 to the Clinic: Learnings from Gene Therapy Applications of Gene Editing".